Adult medulloblastoma: multiagent chemotherapy with cisplatinum and etoposide: a single institutional experience
- 27 August 2011
- journal article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 106 (3), 595-600
- https://doi.org/10.1007/s11060-011-0696-0
Abstract
In 1991, a prospective phase II trial was initiated to evaluate the efficacy of treatment for adults with medulloblastoma (MB). After surgery, patients were staged with a neuroradiologic examination of the brain and neuroaxis and by cerebrospinal fluid cytology. All patients received three cycles of upfront cisplatinum (cisplatinum) and etoposide (VP16) chemotherapy followed by cranio-spinal radiation therapy. The current article reports on the long-term results from that trial. After a median follow-up of 14.9 years, among a total of 28 adults with MB, the overall progression-free survival and overall survival (OS) rates at 5 years were 57.6 and 80%, respectively. The median OS for the whole group of patients was 11.3 years. The observed toxicity was mainly hematological, with leukopenia and thrombocytopenia (16% of grades 3 and 4). In summary, in our small series of patients, the role of combination administration of CDDP + VP16 started before the initiation of radiotherapy in reducing recurrences, particularly distant recurrences, remains unclear. To know whether adding chemotherapy to craniospinal radiation in adult therapy increases relapse-free and overall survival, we must await the results of a larger randomized controlled clinical trial.Keywords
This publication has 27 references indexed in Scilit:
- Survival and prognostic factors in a series of adults with medulloblastomasJournal of Neurosurgery, 2009
- Long‐term results of a prospective study on the treatment of medulloblastoma in adultsCancer, 2007
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Survival and recurrence factors in adult medulloblastoma: The M.D. Anderson Cancer Center experience from 1978 to 1998Neuro-Oncology, 2001
- Adult medulloblastoma: Multiagent chemotherapyNeuro-Oncology, 2001
- Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International society of paediatric oncology (SIOP) and the (German) society of paediatric oncology (GPO): SIOP IIMedical and Pediatric Oncology, 1995
- Hematologic toxicity during craniospinal irradiation: The impact of prior chemotherapyMedical and Pediatric Oncology, 1995
- Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapyJournal of Neurosurgery, 1994
- In vitro chemosensitivity test of human brain tumors using a three-dimensional organ culture with a collagen gel matrixJournal of Neuro-Oncology, 1994
- Medulloblastoma in adults: A review of 47 patients treated between 1952 and 1981International Journal of Radiation Oncology*Biology*Physics, 1990